Literature DB >> 24342642

Population analysis of Escherichia coli isolates with discordant resistance levels by piperacillin-tazobactam broth microdilution and agar dilution testing.

Carole Shubert1, Jen Slaughter, David Creely, Alex van Belkum, Jean Pierre Gayral, William Michael Dunne, Gilles Zambardi, Dee Shortridge.   

Abstract

Population analysis was performed for 42 Escherichia coli isolates to determine whether heterogeneity of resistance was a factor in piperacillin-tazobactam category differences between agar dilution and broth microdilution. Of 20 isolates discordant between methods, 80% were heterogeneous. Of 22 isolates in agreement, 59% were homogeneous. Heterogeneity and homogeneity rates for those in agreement were significantly different from those that were discordant (P value, 0.010). Heterogeneity of resistance expression appears to be an important factor in category differences observed between broth microdilution and agar dilution for piperacillin-tazobactam.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24342642      PMCID: PMC3957839          DOI: 10.1128/AAC.02181-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.

Authors:  F Javier Pérez-Pérez; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  Promoters P3, Pa/Pb, P4, and P5 upstream from bla(TEM) genes and their relationship to beta-lactam resistance.

Authors:  Marie Frédérique Lartigue; Véronique Leflon-Guibout; Laurent Poirel; Patrice Nordmann; Marie-Hélène Nicolas-Chanoine
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

Review 3.  The importance of efflux pumps in bacterial antibiotic resistance.

Authors:  M A Webber; L J V Piddock
Journal:  J Antimicrob Chemother       Date:  2003-01       Impact factor: 5.790

Review 4.  Efflux-mediated antimicrobial resistance.

Authors:  Keith Poole
Journal:  J Antimicrob Chemother       Date:  2005-05-24       Impact factor: 5.790

5.  Irreproducible piperacillin/tazobactam minimum inhibitory concentrations in microdilution tests with Escherichia coli strains.

Authors:  Kenneth S Thomson; Jennifer Black; Ellen Smith Moland; Jay Reuben; Tim Wiles; William Brasso
Journal:  Int J Antimicrob Agents       Date:  2007-11-08       Impact factor: 5.283

6.  International dissemination of Escherichia coli strains with discrepant behaviour in phenotypic antimicrobial susceptibility tests.

Authors:  D Creely; G Zambardi; A van Belkum; Wm M Dunne; M Peyret; J P Gayral; D Shortridge; C Shubert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-02-09       Impact factor: 3.267

7.  Heteroresistance to cephalosporins and penicillins in Acinetobacter baumannii.

Authors:  Kuei-Hsiang Hung; Ming-Cheng Wang; Ay-Huey Huang; Jing-Jou Yan; Jiunn-Jong Wu
Journal:  J Clin Microbiol       Date:  2011-12-21       Impact factor: 5.948

8.  Clinical characteristics of bloodstream infections due to ampicillin-sulbactam-resistant, non-extended- spectrum-beta-lactamase-producing Escherichia coli and the role of TEM-1 hyperproduction.

Authors:  Rebecca I Waltner-Toews; David L Paterson; Zubair A Qureshi; Hanna E Sidjabat; Jennifer M Adams-Haduch; Kathleen A Shutt; Mark Jones; Guo-Bao Tian; Anthony W Pasculle; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2010-12-06       Impact factor: 5.191

9.  Carbapenem Heteroresistance in VIM-1-producing Klebsiella pneumoniae isolates belonging to the same clone: consequences for routine susceptibility testing.

Authors:  M Tato; M Morosini; L García; S Albertí; M T Coque; R Cantón
Journal:  J Clin Microbiol       Date:  2010-09-15       Impact factor: 5.948

10.  Factors determining resistance to beta-lactam combined with beta-lactamase inhibitors in Escherichia coli.

Authors:  J A Reguera; F Baquero; J C Pérez-Díaz; J L Martínez
Journal:  J Antimicrob Chemother       Date:  1991-05       Impact factor: 5.790

View more
  8 in total

1.  A comparison of Sensititre™ Anaerobe MIC plate with ATB ANA® test for the routine susceptibility testing of common anaerobe pathogens.

Authors:  Abdessalam Cherkaoui; Adrien Fischer; Nouria Azam; Arnaud Riat; Jacques Schrenzel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-06       Impact factor: 3.267

2.  Comparative Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Enterobacteriaceae Isolates Producing Extended-Spectrum β-Lactamases from U.S. Hospitals.

Authors:  Mariana Castanheira; Timothy B Doyle; Rodrigo E Mendes; Helio S Sader
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

3.  Epidemiological and clinical features for cefepime heteroresistant Escherichia coli infections in Southwest China.

Authors:  W Ma; J Sun; S Yang; L Zhang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-27       Impact factor: 3.267

Review 4.  Mechanisms and clinical relevance of bacterial heteroresistance.

Authors:  Dan I Andersson; Hervé Nicoloff; Karin Hjort
Journal:  Nat Rev Microbiol       Date:  2019-06-24       Impact factor: 60.633

5.  Ultrasensitive and rapid identification of ESRI developer- and piperacillin/tazobactam-resistant Escherichia coli by the MALDIpiptaz test.

Authors:  Angel Rodríguez Villodres; Lydia Gálvez Benítez; Manuel J Arroyo; Gema Méndez; Luis Mancera; Andrea Vila Domínguez; José Antonio Lepe Jímenez; Younes Smani
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 19.568

6.  Extensive Gene Amplification as a Mechanism for Piperacillin-Tazobactam Resistance in Escherichia coli.

Authors:  Lisa M Schechter; David P Creely; Cherilyn D Garner; Dee Shortridge; Hoan Nguyen; Lei Chen; Blake M Hanson; Erica Sodergren; George M Weinstock; W Michael Dunne; Alex van Belkum; Shana R Leopold
Journal:  MBio       Date:  2018-04-24       Impact factor: 7.867

Review 7.  Multidrug Resistance (MDR) and Collateral Sensitivity in Bacteria, with Special Attention to Genetic and Evolutionary Aspects and to the Perspectives of Antimicrobial Peptides-A Review.

Authors:  András Fodor; Birhan Addisie Abate; Péter Deák; László Fodor; Ervin Gyenge; Michael G Klein; Zsuzsanna Koncz; Josephat Muvevi; László Ötvös; Gyöngyi Székely; Dávid Vozik; László Makrai
Journal:  Pathogens       Date:  2020-06-29

8.  Epidemiological and Molecular Investigations on Salmonella Responsible for Gastrointestinal Infections in the Southwest of Shanghai From 1998 to 2017.

Authors:  Xulin Qi; Pei Li; Xiaogang Xu; Yiqun Yuan; Shurui Bu; Dongfang Lin
Journal:  Front Microbiol       Date:  2019-09-18       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.